{"id":31150,"date":"2024-05-23T07:10:00","date_gmt":"2024-05-23T07:10:00","guid":{"rendered":"https:\/\/g-medtech.com\/news\/?p=31150"},"modified":"2024-05-23T02:41:32","modified_gmt":"2024-05-23T02:41:32","slug":"allez-health-closes-60m-series-a-financing-to-advance-cgm-biosensor-platform","status":"publish","type":"post","link":"https:\/\/g-medtech.com\/news\/allez-health-closes-60m-series-a-financing-to-advance-cgm-biosensor-platform\/","title":{"rendered":"Allez Health Closes $60M Series A+ Financing to Advance CGM Biosensor Platform"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Allez Health has closed a $60 million Series A+ financing led by Korean in-vitro diagnostics company Osang Healthcare, with participation from existing investors, to accelerate growth towards pivotal trials, support regulatory submissions and scale manufacturing operations.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Allez Health is a pioneering continuous glucose monitoring (CGM) biosensor platform with novel sensor technology and has achieved several significant milestones in patents, clinical trials and a pivotal study in 120 insulin users, and is expected to accelerate its progress towards commercialization in multiple global markets.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">We are committed to bringing to market a sensor that combines access, affordability and reliable performance,&#8221; said Leif Bowman, co-founder and CEO of Allez Health. Allez Health&#8217;s innovative design and technical advances, coupled with Osang&#8217;s manufacturing capabilities and global reach, will provide meaningful access to world-class CGM technology for millions of people with diabetes,&#8221; said Dr Chulhun Kang, CEO of Osang Healthcare.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>to invest in operations, clinical development and commercialization endeavors<\/p>\n","protected":false},"author":2,"featured_media":31151,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"colormag_page_layout":"default_layout","footnotes":""},"categories":[488,681,10],"tags":[594],"class_list":["post-31150","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-breaking-news","category-care-therapy","category-strategic-development","tag-financing"],"_links":{"self":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts\/31150","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/comments?post=31150"}],"version-history":[{"count":1,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts\/31150\/revisions"}],"predecessor-version":[{"id":31152,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts\/31150\/revisions\/31152"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/media\/31151"}],"wp:attachment":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/media?parent=31150"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/categories?post=31150"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/tags?post=31150"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}